New Trends in Esophageal Cancer Management (Volume II)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (15 August 2024) | Viewed by 9527
Special Issue Editor
Interests: esophageal cancer; esophageal adenocarcinoma; esophageal squamous cell carcinoma; surgery; chemoradiotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the second edition of the Special Issue “New Trends in Esophageal Cancer Management”, available at https://www.mdpi.com/journal/cancers/special_issues/Esophageal_Cancer_Management.
Esophageal cancer retains the reputation of having a poor prognosis, due to having a generally evolved stage at the time of diagnosis, a terrain often altered by multiple co-morbidities, a rapid impact on the general state, particularly nutritional, and a need for cumbersome combinations of treatments, in particular, complex surgery. However, significant progress has been made over the last few decades. This has involved achieving better precision in pre-therapeutic assessments, making it possible to adjust the treatment modalities effectively; developing effective chemotherapies with acceptable side-effects; improving radiotherapy techniques that make it possible to concentrate high doses within a limited volume while sparing neighborhood structures; and improving surgical management, both at the level of perioperative care and during the surgical act itself, where the site of minimally-invasive surgery is clearer. Although the morbidity and mortality of esophagectomies remain some of the highest in gastrointestinal surgery, they have drastically decreased over the last few decades, allowing surgery to remain the primary treatment for resectable esophageal cancer. Additionally, due to therapeutic advances, it has become possible to manage much older patients too. At the same time, the epidemiological profile of this cancer has changed radically, due to a reduction in alcohol and tobacco consumption and an increase in the incidence of gastroesophageal reflux disease (GERD). Thus, adenocarcinoma of the esophagus has become more frequent than squamous cell carcinoma in Western countries; therefore, its tendency will be considered here too in order to group together this pathology in regard to center-specialized high-volume activity.
The objective of this Special Issue is to provide an overview of the current management of esophageal cancer concerning pre-treatment assessment, perioperative treatment, nutritional management, surgical treatment, and special situations. It aims to serve as an aid in the daily practice of physicians confronted with esophageal cancer.
Prof. Dr. Caroline Gronnier
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- esophageal cancer
- esophageal adenocarcinoma
- esophageal squamous cell carcinoma
- surgery
- chemoradiotherapy
- perioperative chemotherapy
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.